Dolby Laboratories, Inc.
DLB
$54.06
-$0.06-0.11%
NYSE
| 03/27/2026 | 12/26/2025 | 09/26/2025 | 06/27/2025 | 03/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.39% | 1.80% | 5.92% | 6.94% | 4.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.39% | 1.80% | 5.92% | 6.94% | 4.03% |
| Cost of Revenue | 17.22% | 8.95% | 13.98% | 8.84% | -1.10% |
| Gross Profit | 1.66% | 0.89% | 4.92% | 6.70% | 4.71% |
| SG&A Expenses | 4.48% | 3.10% | 7.01% | 5.76% | 2.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.50% | 3.25% | 5.96% | 4.44% | 0.65% |
| Operating Income | -4.36% | -3.60% | 5.76% | 17.21% | 18.66% |
| Income Before Tax | -8.76% | -9.02% | -2.88% | 22.83% | 34.34% |
| Income Tax Expenses | -24.80% | -11.27% | -2.43% | 20.31% | 32.64% |
| Earnings from Continuing Operations | -5.21% | -8.57% | -2.96% | 23.38% | 34.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 22.94% | 26.13% | 40.83% | 50.36% | -27.80% |
| Net Income | -5.06% | -8.43% | -2.60% | 24.39% | 34.79% |
| EBIT | -4.36% | -3.60% | 5.76% | 17.21% | 18.66% |
| EBITDA | -1.02% | -0.12% | 8.09% | 16.87% | 15.80% |
| EPS Basic | -4.72% | -8.71% | -2.98% | 24.05% | 34.45% |
| Normalized Basic EPS | -6.10% | -4.32% | 0.01% | 10.24% | 14.18% |
| EPS Diluted | -4.19% | -8.50% | -2.61% | 24.15% | 34.63% |
| Normalized Diluted EPS | -5.60% | -4.15% | 0.20% | 10.58% | 14.60% |
| Average Basic Shares Outstanding | -0.21% | 0.24% | 0.34% | 0.20% | 0.15% |
| Average Diluted Shares Outstanding | -0.62% | 0.05% | 0.13% | -0.21% | -0.32% |
| Dividend Per Share | 9.30% | 9.52% | 9.76% | 10.00% | 10.26% |
| Payout Ratio | 0.15% | 0.20% | 0.13% | -0.11% | -0.18% |